Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Westhoff, Mike-Andrew  [Clear All Filters]
2024
Schneider M, Potthoff A-L, Karpel-Massler G, Schuss P, Siegelin MD, Debatin K-M, Duffau H, Vatter H, Herrlinger U, Westhoff M-A. The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours. Mol Oncol. 2024.
2016
Giese M, Turiello N, Molenda N, Palesch D, Meid A, Schroeder R, Basilico P, Benarafa C, Halatsch M-E, Zimecki M, et al. Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells. Oncotarget. 2016.
Karpel-Massler G, Banu MA, Shu C, Halatsch M-E, Westhoff M-A, Bruce JN, Canoll P, Siegelin MD. Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo. Oncotarget. 2016.
2015
Schneider M, Ströbele S, Nonnenmacher L, Siegelin MD, Tepper M, Stroh S, Hasslacher S, Enzenmüller S, Strauss G, Baumann B, et al. A paired comparison between glioblastoma 'stem cells' and differentiated cells. Int J Cancer. 2015.
Ströbele S, Schneider M, Schneele L, Siegelin MD, Nonnenmacher L, Zhou S, Karpel-Massle G, Westhoff M-A, Halatsch M-E, Debatin K-M. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy. PLoS One. 2015;10(6):e0131670.
Karpel-Massler G, Bâ M, Shu C, Halatsch M-E, Westhoff M-A, Bruce JN, Canoll P, Siegelin MD. TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo. Oncotarget. 2015.